It Seems Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) Will Go Up. Just Reported Less Shorted Shares

June 18, 2018 - By Clifton Ray

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Logo

The stock of Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) registered a decrease of 9.29% in short interest. APHB’s total short interest was 930,000 shares in June as published by FINRA. Its down 9.29% from 1.03M shares, reported previously. With 181,600 shares average volume, it will take short sellers 5 days to cover their APHB’s short positions.

The stock 0.01% or $0 during the last trading session, reaching $1.26. It is down 59.19% since June 18, 2017 and is uptrending. It has outperformed by 46.62% the S&P500.

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage technology. The company has market cap of $20.79 million. It is also developing targeted and personalized bacteriophage therapies for patients with serious or life-threatening antibiotic-resistant infections. It currently has negative earnings. The firm has reported results from two Phase I clinical trials of AB-SA01 for the treatment of Staphylococcus aureus in chronic rhinosinusitis patients, as well as evaluating the safety of AB-SA01 when administered topically to the intact skin of healthy adults.

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: